BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 9329065)

  • 21. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.
    Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):486-94. PubMed ID: 11160635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caffeine expectancies influence the subjective and behavioral effects of caffeine.
    Harrell PT; Juliano LM
    Psychopharmacology (Berl); 2009 Dec; 207(2):335-42. PubMed ID: 19760283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the role of expectancy in caffeine withdrawal using the balanced placebo design.
    Juliano LM; Kardel PG; Harrell PT; Muench C; Edwards KC
    Hum Psychopharmacol; 2019 Mar; 34(2):e2692. PubMed ID: 30861208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caffeine withdrawal: a parametric analysis of caffeine dosing conditions.
    Evans SM; Griffiths RR
    J Pharmacol Exp Ther; 1999 Apr; 289(1):285-94. PubMed ID: 10087016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caffeine in sport. Urinary excretion of caffeine in healthy volunteers after intake of common caffeine-containing beverages.
    van der Merwe PJ; Müller FR; Müller FO
    S Afr Med J; 1988 Aug; 74(4):163-4. PubMed ID: 3406872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive and psychomotor performance, mood, and pressor effects of caffeine after 4, 6 and 8 h caffeine abstinence.
    Heatherley SV; Hayward RC; Seers HE; Rogers PJ
    Psychopharmacology (Berl); 2005 Apr; 178(4):461-70. PubMed ID: 15696321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is caffeine a flavoring agent in cola soft drinks?
    Griffiths RR; Vernotica EM
    Arch Fam Med; 2000 Aug; 9(8):727-34. PubMed ID: 10927712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caffeine withdrawal and high-intensity endurance cycling performance.
    Irwin C; Desbrow B; Ellis A; O'Keeffe B; Grant G; Leveritt M
    J Sports Sci; 2011 Mar; 29(5):509-15. PubMed ID: 21279864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced stimulant and metabolic effects of combined ephedrine and caffeine.
    Haller CA; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2004 Apr; 75(4):259-73. PubMed ID: 15060505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survey of caffeine levels in retail beverages in Portugal.
    Pena A; Lino C; Silveira MI
    Food Addit Contam; 2005 Feb; 22(2):91-6. PubMed ID: 15823997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consumption of dietary caffeine and coffee in physically active populations: physiological interactions.
    Tunnicliffe JM; Erdman KA; Reimer RA; Lun V; Shearer J
    Appl Physiol Nutr Metab; 2008 Dec; 33(6):1301-10. PubMed ID: 19088792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose caffeine physical dependence in humans.
    Griffiths RR; Evans SM; Heishman SJ; Preston KL; Sannerud CA; Wolf B; Woodson PP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1123-32. PubMed ID: 2262896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of placebo awareness on stimulant drug response in a double-blind trial.
    Nash JM; Holroyd KA; Rokicki LA; Kvaal S; Penzien DB
    Psychopharmacology (Berl); 2002 May; 161(3):213-21. PubMed ID: 12021824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Misclassification of exposure: coffee as a surrogate for caffeine intake.
    Brown J; Kreiger N; Darlington GA; Sloan M
    Am J Epidemiol; 2001 Apr; 153(8):815-20. PubMed ID: 11296156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caffeine content of prepackaged national-brand and private-label carbonated beverages.
    Chou KH; Bell LN
    J Food Sci; 2007 Aug; 72(6):C337-42. PubMed ID: 17995675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Semiquantitative study of current coffee, caffeine, and ethanol intake in essential tremor cases and controls.
    Louis ED; Jurewicz EC; Applegate L; Luchsinger JA; Factor-Litvak P; Parides M
    Mov Disord; 2004 May; 19(5):499-504. PubMed ID: 15133812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of caffeine and caffeine withdrawal on mood and cognitive performance degraded by sleep restriction.
    Rogers PJ; Heatherley SV; Hayward RC; Seers HE; Hill J; Kane M
    Psychopharmacology (Berl); 2005 Jun; 179(4):742-52. PubMed ID: 15887055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute Caffeinated Coffee Consumption Does not Improve Time Trial Performance in an 800-m Run: A Randomized, Double-Blind, Crossover, Placebo-Controlled Study.
    Marques AC; Jesus AA; Giglio BM; Marini AC; Lobo PCB; Mota JF; Pimentel GD
    Nutrients; 2018 May; 10(6):. PubMed ID: 29789507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of different protocols of caffeine intake on metabolism and endurance performance.
    Cox GR; Desbrow B; Montgomery PG; Anderson ME; Bruce CR; Macrides TA; Martin DT; Moquin A; Roberts A; Hawley JA; Burke LM
    J Appl Physiol (1985); 2002 Sep; 93(3):990-9. PubMed ID: 12183495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.